chartexchange

RCKT
Rocket Pharmaceuticals, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 9:50:17 AM EST
2.16USD+2.370%(+0.05)101,087
Pre-marketNov 19, 2026 8:53:30 AM EST
2.115USD+0.237%(+0.005)
2.1700Bid2.1900Ask0.0200Spread

RCKT Financials

In Q3 FY 2026 (ended ), Rocket Pharmaceuticals, Inc. Common Stock (RCKT) reported revenue of $0, net income of −$49.23M, operating cash flow of −$39.05M, and assets of $419.5M (filed ).

Loading financial statements…